Stanford researchers have developed a next-generation programmable transcriptional activation platform, TIGRa, that addresses key limitations of CRISPRa technologies, including large size, limited multiplexing capacity, and delivery constraints.
Stanford researchers have developed Microbe-Independent Deep Assembly and Screening (MIDAS-M), a novel platform that dramatically accelerates the cloning of protein variants and its analysis in mammalian cells.
Stanford scientists have developed a thin, wearable electrode array patch capable of non-invasively recording high-resolution electrical signals through the skin of the body's internal organs, offering a new window into physiological processes that have historically been diffi
Researchers in Prof. Mark Schnitzer's laboratory have developed a robotic optical microscopy system which enables users to simultaneously view and record separate areas of a single three-dimensional sample.
Imaging methods that can visualize biological samples with high and temporal resolution are critical for modern biomedical research and clinical practice.
Stanford scientists have discovered novel high molecular weight isoforms of thymic stromal lymphopoietin (TSLP), measured using nanoimmunoassay (NIA), that can serve as a blood-based biomarker for the diagnosis and prognostication of acute graft versus host disease (aGVHD).
Researchers from Stanford have developed a novel topical pharmaceutical composition comprising of a chemical inhibitor encapsulated in nanomicelles for the treatment of vision loss associated with acute optic neuropathies.
Stanford researchers have developed a targeted antisense oligonucleotide (ASO) platform to restore physiological regulation of DYRK1A, a key driver of neurodevelopmental and neurodegenerative pathology in Down syndrome (Trisomy 21) and other tauopathies.
Researchers at Stanford, in collaboration with UCSF, have developed a two-part approach to preventing preterm birth (PTB), the leading cause of infant mortality worldwide. Current treatments, like low-dose aspirin and progesterone, are limited and often ineffective.
Stanford researchers have developed an innovative nucleic acid amplification method that enables low-cost, multiplexed detection while quantitatively maintaining the original ratios of target genes after amplification.
Scientists at Stanford have developed a novel imaging approach that enables high-resolution, label-free visualization of subcellular structures in living cells.
Researchers at Stanford have developed a platform to design and screen novel chimeric large serine recombinases (LSRs), enzymes capable of inserting large DNA payloads into precise locations in the genome.
Researchers from Stanford developed chemically modified adeno-associated virus (AAV) capsids that enable selective gene delivery to either exocrine or endocrine pancreatic cells through unnatural amino acid incorporation and peptide conjugation.
Stanford researchers have developed a label-free platform that combines surface-enhanced Raman spectroscopy (SERS) with machine learning to enable rapid, non-destructive profiling of cell identity and functional state at single-cell resolution.